Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tom Gallen

Managing Editor, Europe

Birmingham, UK
Tom reports and edits European consumer health care industry news and analysis. Leading HBW Insight’s health and wellness coverage in Europe, he has been writing about the sector since 2013. Tom’s main focus is analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios. He also reports on regulatory topics such as novel foods and prescription-to-OTC switches.

Latest From Tom Gallen

UK Proposes Accelerating Authorizations Of Novel Supplements Like CBD

UK Food Standards Agency proposes shaving a minimum of three months off novel food authorization procedure as part of wider plans to shake-up the process for products like CBD supplements.

Approvals Dietary Supplements

Poland's President Blocks Rx-To-OTC Switch Of Emergency Contraceptive Pill

Citing a will to protect children's health, Poland's president has blocked a bill which would have restored OTC access to the morning after pill to those aged 15 and above. In response, the health ministry has drawn up a proposal to allow pharmacists to issue prescriptions for emergency contraception.

Prescription To OTC Switch Poland

People On The Move: Appointments At Vectura Fertin, PAGB, Dr. Kade

A round-up of the latest appointments in Europe's consumer health market: Vectura Fertin names president; PAGB makes board addition; Dr. Kade names CCO.

Executive Changes Leadership

Japan's Rohto Snaps Up TCM Specialist To Grow In Asia

In a deal worth around $600m, Rohto Pharmaceutical is poised to expand its dietary supplements offering in Southeast Asia through the acquisition of a controlling stake in Singapore's Eu Yan Sang.

Deals Asia Pacific

CBD Among Novel Food Ingredients Targeted By EU Enforcement Authorities In Q1

Dietary supplements containing unsafe or unauthorized substances were reported to the European Commission by national regulators on around 60 occasions in the first quarter of 2024.

Enforcement Dietary Supplements

Timely Acquisition Keeps Germany's Dermapharm Growing

With its Branded Pharmaceuticals division negatively impacted by the end of the COVID-19 pandemic, the timely acquisition of supplements firm Arkopharma ensured Dermapharm recorded double-digit sales growth in 2023.

Sales & Earnings Dietary Supplements
See All
UsernamePublicRestriction

Register